TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · major macro event coming up
TRVI

Trevi Therapeutics Inc

Healthcare · Biotechnology

14.40$ -1.8% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

Trevi Therapeutics Inc (TRVI) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 331 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet TRVI
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
96 89 79 74 69 111 107 208 199 193 180 331
94 88 77 72 67 109 106 207 198 192 176 326
26 32 14 13 16 34 19 117 57 19 19 54
89 83 73 69 65 108 103 204 195 188 172 319
– – – – – 0.5 – – – 1.0 – 1.6
6.3 6.9 6.2 7.6 9.9 11 7.5 9.8 9.6 10 7.5 9.0
5.2 5.8 5.3 6.8 9.1 11 6.9 9.2 9.0 9.7 7.1 8.7
0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3
1.3 1.8 2.1 1.5 1.6 3.4 1.4 3.0 2.7 3.9 2.2 3.1
90 83 72 66 59 100 99 198 190 183 172 322
-231 -239 -250 -262 -276 -287 -297 -310 -321 -330 -343 -361
99 99 100 101 101 106 118 130 145 146 146 157

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?